Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ventripoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

VentriPoint Diagnostics Ltd is a Canada based medical device company. It is primarily engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure and normal hearts. It sells its products in Canada and internationally.


Recent & Breaking News (TSXV:VPT)

Ventripoint Signs on Arc Group Medical LLC as Distributor in Florida Region

TheNewsWire 3 days ago

Ventripoint Appoints MediTek Lifesciences LLC as Distributor for California

TheNewsWire November 17, 2022

Ventripoint to Sponsor the Annual Meeting of the British Congenital Cardiac Association

TheNewsWire November 4, 2022

Ventripoint Diagnostics Provides a Corporate Update and Announces New Investor Relations Initiative

TheNewsWire October 27, 2022

Ventripoint Diagnostics (TSXV:VPT) exhibiting at the 2022 British Society of Echocardiography

Shoran Devi October 14, 2022

Ventripoint Diagnostics Exhibiting at the 2022 British Society of Echocardiography

TheNewsWire October 14, 2022

Ventripoint (TSXV:VPT) announces sponsorship for the European Society of Cardiology congress

Shoran Devi August 26, 2022

Ventripoint Announces Sponsorship for the European Society of Cardiology Congress 2022

TheNewsWire August 26, 2022

Echocardiologists in Latin America Express Strong Interest in Ventripoint Whole Heart Analysis Products

TheNewsWire August 10, 2022

Single Ventricle Congenital Heart Disease Study Launches at Leading Academic Medical Center using Ventripoint's VMS+3.0 Whole-Heart Analysis System

TheNewsWire June 29, 2022

Ventripoint Exhibiting at the American Society of Echocardiography 33rd Annual Scientific Session

TheNewsWire June 7, 2022

Ventripoint Announces Sponsorship of the 55th Annual Meeting of the Association for European Paediatric and Congenital Cardiology

TheNewsWire May 17, 2022

Ventripoint Hires Two Strategic Sales Account Managers for US, Europe, and UK Distribution

TheNewsWire May 9, 2022

Ventripoint Announces Sponsorship for the 2022 SickKids Echo Symposium

TheNewsWire May 3, 2022

Ventripoint Welcomes Dr. Jose Banchs as New Clinical Advisor

TheNewsWire April 27, 2022

Ventripoint Welcomes Dr. Howard Michael Leong-Poi as New Clinical Advisor

TheNewsWire April 19, 2022

Ventripoint Signs on AngioConsult/Angiopro as European Distributor

TheNewsWire April 7, 2022

Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options

TheNewsWire April 1, 2022

Ventripoint Announces DTC Eligibility Approval in the U.S.

TheNewsWire March 21, 2022

Ventripoint Hires Social Media Firm North Equities Corp.

TheNewsWire March 2, 2022